Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients

NCT01069965 is registered in ClinicalTrials.gov with N-Gene Research Laboratories, Inc. as lead sponsor.

NCT NCT01069965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01069965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multiple Dose, Multicenter Study to Assess Safety & Efficacy of BGP-15 Administered Orally 1 or 2 Times Daily With Metformin & Sulfonylurea or Metformin in T2 Diabetic Patients
Lead sponsor
N-Gene Research Laboratories, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2010
Completion date
October 31, 2011
Enrollment
196 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus